Bremelanotide
PT-141
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide and a metabolite of melanotan-II that binds melanocortin receptors, particularly MC4R. It is used in vitro to study melanocortin (MC4R) signalling and cAMP-pathway activation. Supplied as a lyophilized reference standard for laboratory research.
Quality assured
≥99.1% HPLC · LC-MS identity · discreet packaging
Tracked EU shipping
DHL GoGreen €19.90 (7–14 d) · Express €59.90 (3–5 d)
Secure payment
SEPA bank transfer · IBAN emailed · no card needed
Independent verification
Lab analysesHPLC
≥99.1%
LC-MS
Identity
Analysis
Batch P141-1006
Every batch is independently lab-analysed (HPLC · LC-MS · Janoshik) — see the published batch analyses.
Research use only. This reference material is for in-vitro laboratory research. Not for human or animal consumption.
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide and a metabolite of melanotan-II that binds melanocortin receptors, particularly MC4R. It is used in vitro to study melanocortin (MC4R) signalling and cAMP-pathway activation. Supplied as a lyophilized reference standard for laboratory research.
Supplied as a lyophilized powder in a light-protected vial, each batch is released only after purity is confirmed by HPLC and identity by LC-MS. Every batch is independently analysed — the batch analyses are published under Lab analyses.
For the full research profile — classification, molecular data, mechanism and research fields — see the PT-141 lexicon entry.
Frequently asked
The Peptide Cyprus standard
Every batch is released only after ≥99.1% HPLC purity and LC-MS identity confirmation, and is independently lab-analysed — the batch analyses are published under Lab analyses.
Purity verified
HPLC + LC-MS per batch
Batch analysis
Independently lab-verified
Discreet EU shipping
Tracked & light-protected
Pairs well with
PT-141 · 10 mg · 5×
€202.05